Key result
Novel RP-HPLC method enables rapid, precise simultaneous estimation of aspirin and clopidogrel.
Why the study?
A validated, simple, and rapid RP-HPLC method was needed for simultaneous estimation of aspirin and clopidogrel bisulphate in tablet dosage forms used in cardiovascular treatment.
A validated RP-HPLC method was developed for the simultaneous estimation of aspirin and clopidogrel in tablet formulations.
Answers are grounded in this paper and cite their sources.
May support quality control of aspirin-clopidogrel tablets; leaves open routine adoption pending independent verification.
A simple, rapid, precise RP-HPLC method was developed for simultaneous estimation of aspirin and clopidogrel bisulphate in tablet dosage form used in the treatment of cardiovascular diseases. To achieve the maximum resolution, acetonitrile:50 mM potassium dihydrogen phosphate buffer:methanol, solution pH adjusted to 3, in the ratio 50:30:20; v/v was selected as mobile phase. This mixture was found to be appropriate allowing good separation of both the components at a flow rate of 1.5 ml/min and detection wavelength 240 nm. In these conditions clopidogrel bisulfate and aspirin were eluated at the 7.47 and 2.2 min. The linearity was found in the concentration range 1.5-7.5 and 3.5-15.0 μg/ml, respectively. All the analytical validation parameters were determined and found with in the limit as per ICH guideline, which indicates the validity of method.
No takes yet. Share an insight, caveat, or question.
Shrivastava et al. (2008) studied cardiovascular diseases. RP-HPLC method was evaluated on Simultaneous estimation of aspirin and clopidogrel bisulphate. A simple, rapid, and precise RP-HPLC method was successfully developed and validated for the simultaneous estimation of aspirin and clopidogrel bisulphate in tablet dosage forms.
Synapse has enriched 10 related papers. Consider them for comparative context: